ES2062006T3 - Un psti humano modificado. - Google Patents

Un psti humano modificado.

Info

Publication number
ES2062006T3
ES2062006T3 ES89307309T ES89307309T ES2062006T3 ES 2062006 T3 ES2062006 T3 ES 2062006T3 ES 89307309 T ES89307309 T ES 89307309T ES 89307309 T ES89307309 T ES 89307309T ES 2062006 T3 ES2062006 T3 ES 2062006T3
Authority
ES
Spain
Prior art keywords
modified human
human psti
dna sequences
psti
asur
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89307309T
Other languages
English (en)
Inventor
Nobuo Yoshida
Norihisa Kikuchi
Hiroshi Teraoka
Masaru Shin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Application granted granted Critical
Publication of ES2062006T3 publication Critical patent/ES2062006T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8135—Kazal type inhibitors, e.g. pancreatic secretory inhibitor, ovomucoid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/843—Digestive system
    • Y10S530/845—Pancreas

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

SECUENCIAS DE DNA, QUE CODIFICAN VARIEDADES MODIFICADAS DE PSTI HUMANO, TIENEN EXCELENTE ESTABILIDAD EN EL SENTIDO DE SUSCEPTIBILIDAD DISMINUIDA A LA DESCOMPOSICION POR ENZIMAS PROTEOLITICOS, TALES COMO TRIPSINA, EN COMPARACION CON PSTI HUMANO NATURAL, ASI COMO LAS VARIEDADES MODIFICADAS DE PSTI HUMANO OBTENIDAS POR LA EXPRESION DE DICHAS SECUENCIAS DE DNA.
ES89307309T 1988-07-19 1989-07-19 Un psti humano modificado. Expired - Lifetime ES2062006T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18131688 1988-07-19
JP63255580A JPH07102137B2 (ja) 1988-07-19 1988-10-11 修飾ヒトｐｓｔｉ

Publications (1)

Publication Number Publication Date
ES2062006T3 true ES2062006T3 (es) 1994-12-16

Family

ID=26500552

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89307309T Expired - Lifetime ES2062006T3 (es) 1988-07-19 1989-07-19 Un psti humano modificado.

Country Status (8)

Country Link
US (1) US5122594A (es)
EP (1) EP0352089B1 (es)
JP (1) JPH07102137B2 (es)
KR (1) KR960015745B1 (es)
AU (1) AU612865B2 (es)
CA (1) CA1339875C (es)
DE (1) DE68913090T2 (es)
ES (1) ES2062006T3 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591603A (en) * 1987-08-28 1997-01-07 Novo Nordisk A/S Process for preparing aprotinin and aprotinin analogs in yeast cells
US5231010A (en) * 1989-09-13 1993-07-27 Bayer Aktiengesellschaft Recombinant aprotinin variants genetically engineered process for the microbial preparation of homogeneously processed aprotinin variants and the therapeutic use thereof
JPH0751066B2 (ja) * 1990-09-14 1995-06-05 重三 鵜高 プロテアーゼインヒビター遺伝子及び該遺伝子を保有する微生物並びに該微生物を用いるプロテアーゼインヒビターの製造法
IL104314A0 (en) * 1992-01-07 1993-05-13 Novo Nordisk As Human kunitz-type protease inhibitor and variants thereof,their production and pharmaceutical compositions containing them
JP3626982B2 (ja) * 1997-08-29 2005-03-09 アークレイ株式会社 タンパク質分解酵素阻害物質の測定方法およびそれに用いる測定キット
US6087558A (en) * 1998-07-22 2000-07-11 Prodigene, Inc. Commercial production of proteases in plants
ES2566385T3 (es) * 2007-02-12 2016-04-12 Csl Behring Gmbh Aplicación terapéutica de inhibidores de la proteasa de serina de tipo Kazal

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0264118B1 (en) * 1986-10-14 1993-08-04 SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI & CO. LTD. Novel method for preparing proteins
JPS63267289A (ja) * 1986-10-14 1988-11-04 Shionogi & Co Ltd 蛋白質の新規製法
WO1988003171A1 (en) * 1986-10-30 1988-05-05 Synergen Biologicals, Inc. Human pancreatic secretory trypsin inhibitors produced by recombinant dna methods and processes for the production of same
GB2199582A (en) * 1987-01-07 1988-07-13 Bayer Ag Analogues of pancreatic secretory trypsin inhibitor

Also Published As

Publication number Publication date
DE68913090D1 (de) 1994-03-24
CA1339875C (en) 1998-05-19
EP0352089A3 (en) 1990-08-16
KR900001853A (ko) 1990-02-27
JPH02150282A (ja) 1990-06-08
AU3797889A (en) 1990-01-25
DE68913090T2 (de) 1994-05-26
US5122594A (en) 1992-06-16
EP0352089A2 (en) 1990-01-24
AU612865B2 (en) 1991-07-18
EP0352089B1 (en) 1994-02-16
KR960015745B1 (ko) 1996-11-20
JPH07102137B2 (ja) 1995-11-08

Similar Documents

Publication Publication Date Title
ATE114169T1 (de) Morphogenetisches knochenprotein.
ES2235164T3 (es) Variantes de subtilisina.
ES2163864T3 (es) Secuencias de dna de 2-desoxiglucosa-6-fosfato (2-dog-6-p) como marcador de seleccion en plantas.
ATE56471T1 (de) Dns-sequenzen, rekombinante dns-molekuele und verfahren zur herstellung von dem menschlichen fibroblast-interferon.
DK0471754T3 (da) Produktion af vaskulær endotelcelle vækstfaktor, samt DNA kodende for denne
ES2061632T5 (es) Kluyveromyces como celula hospedante.
KR890700668A (ko) 섭티리신 동촉체
DK288183A (da) Fremgangsmaade til fremstilling af et oligonucleotidt terapeutisk middel
ES2082003T3 (es) Deshidrodidemnina b.
DE69033626D1 (de) Mittel zur Hemmung des Komplementsystems hergestellt aus Fucanen aus braunen Algen
ES2091224T3 (es) Subtilisinas con mutaciones multiples.
NO870301L (no) Vippemekanisme, fortrinnsvis for stolsete eller lignende.
FR2762850B1 (fr) Lactoferrines recombinantes, leurs procedes de production par les plantes ainsi que leurs utilisations
ES2119411T3 (es) Combinaciones de proteinas y anticoagulantes tromboliticamente activos, y usos de los mismos.
ES2062006T3 (es) Un psti humano modificado.
ATE215988T1 (de) Vitamin-k-abhängige carboxylase
LU90781I2 (fr) Fasturtec -rasburicase
MX9203138A (es) Dominio de enlace cd2-de antigeno 3 (lfa-3) asociado con funcion linfositos.
ES2171563T3 (es) Nueva familia de inhibidores de proteasas, y otras sustancias de actividad biologica.
DE59404861D1 (de) Gewebe zur Verstärkung bzw. Armierung von Flächengebilden
DE69534470T2 (de) Lgmd- gen kodierend für eine calcium-abhängige protease
DE68929340D1 (de) Pflanzenverlängerungsfaktor, promotoren, kodierende sequenzen und verwendungen
FI874996A0 (fi) Diamidien käyttö pehmennysaineena pesuainekoostumuksissa
ES2091223T3 (es) Nuevas secuencias de adn que codifican polipeptidos semejantes a ancrod y composiciones que comprenden los productos de expresion de las mismas.
DE59404066D1 (de) Gewebe zur Verstärkung bzw. Armierung von Flächengebilden

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 352089

Country of ref document: ES